Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

27277studies shown

Showing 3,517-3,528 of 27,277

RecruitingNCT00025935

Studies of Brain Function and Course of Illness in Pediatric Bipolarity

Official study title

Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth

In Bethesda

BipolarityObservational studyAges 7–85

Countries: United States
Sponsor: National Institute of Mental Health (NIMH) (Government agency)

View study

RecruitingNCT05778734

Problem-solving therapy and incentives for alcohol abstinence in young adults

About this title

StuDy AimED at Increasing AlCohol AbsTinEnce

Read the official source — NCT05778734

Official study title

StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)

In Chicago

AddictionBehavioural studyAges 18–24

Countries: United States
Sponsor: University of Illinois Chicago

View study

RecruitingNCT06129903

Early mental health referral around sarcoma surgery

About this title

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

Read the official source — NCT06129903

Official study title

The Effect of Enhanced Behavioral Healthcare on Self-Reported Depression, Anxiety, and Health-Related Quality of Life Among Patients With Musculoskeletal Sarcoma Undergoing Surgery: A Randomized Pilot Study

Multiple locations, including Basking Ridge

AnxietyInterventional studyAges 18+

Countries: United States
Sponsor: Memorial Sloan Kettering Cancer Center

View study

RecruitingNCT05540704

ACT, diabetes counseling, or waitlist for eating concerns in type 1 diabetes

About this title

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

Read the official source — NCT05540704

Official study title

Changing the T1DE (Type 1 Diabetes Eating Disorders): A Randomized Controlled Trial Comparing Acceptance and Commitment Therapy (ACT) to Supportive Diabetes Counseling and a Waitlist Control

Multiple locations, including Durham

Eating disordersBehavioural studyAges 16–50

Countries: United States
Sponsor: Duke University

View study

RecruitingNCT07110896

Humiome Post LB and stress, anxiety, and cognition in older adults

About this title

Study Evaluating the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults

Read the official source — NCT07110896

Official study title

A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults

Multiple locations, including Paris

AnxietyPlacebo comparisonAges 50–75

Countries: France, Germany
Sponsor: dsm-firmenich Switzerland AG

View study

RecruitingACTRN12621001434886

Study investigating whether the drug semaglutide could be a safe and effective way of reducing metabolic problems, such as a high Body Mass Index (BMI) and high blood sugar levels, in people with psychosis.

Official study title

Open label randomised controlled trial of the glucagon like peptide-1 receptor agonist (GLP1RA) semaglutide vs usual care for metabolic risk in people with psychosis.

In Randwick

SchizophreniaInterventional studyAges 18–65

Countries: Australia
Sponsor: South Eastern Sydney Local Health District

View study

RecruitingNCT06633016

ABX-002 or placebo added to antidepressants for depression

About this title

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Read the official source — NCT06633016

Official study title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder

Multiple locations, including Birmingham

DepressionMedication studyAges 18–65

Countries: United States
Sponsor: Autobahn Therapeutics, Inc.

View study

RecruitingNCT06502964

ALTO-101 or placebo patch for cognition in people with schizophrenia

About this title

Study of ALTO-101 in Patients With Schizophrenia

Read the official source — NCT06502964

Official study title

Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment

Multiple locations, including Garden Grove

SchizophreniaMedication studyAges 21–55

Countries: United States
Sponsor: Alto Neuroscience

View study

RecruitingNCT05922878

ALTO-300 or placebo added to antidepressant treatment for major depression

About this title

Study of ALTO-300 in MDD

Read the official source — NCT05922878

What is this study about?

Researchers are comparing ALTO-300 and placebo to find out how the approaches affect depression symptoms in adults with depression.

Multiple locations, including Phoenix

DepressionMedication studyAges 18–70

Countries: United States
Sponsor: Alto Neuroscience

View study

RecruitingNCT06891235

Remote oral fluid testing to measure cannabis use

About this title

Study of an Oral Fluid Testing Approach

Read the official source — NCT06891235

Official study title

Oral Fluid Testing to Assess Cannabis Non-Use in Remote Clinical Trials

In Boston

AddictionObservational studyAges 18–35

Countries: United States
Sponsor: Boston Children's Hospital

View study

RecruitingNCT07278505

Cannabidiol and Neuroimaging on Stress

Official study title

Pathophysiological Mechanisms of Cannabidiol in Stress Regulation

In New York

AnxietyMedication studyAges 18–25

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.